Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant Injectable Emulsion for Prevention of Postoperative Nausea and Vomiting
CTR20242632Phase 3Completed
- Sponsor
- CSPC Zhongnuo Pharmaceutical
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by CSPC Zhongnuo Pharmaceutical. Started Jul 2024; status: completed.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on CTR20242632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242632.